APELOA(000739) 搜狐财经·2025-04-02 17:46Core Viewpoint - Prolo Pharmaceutical Co., Ltd. is currently engaged in a share repurchase plan aimed at implementing employee stock ownership and incentive programs, with a maximum repurchase price set at 22 RMB per share and a total repurchase fund between 75 million and 150 million RMB [2][4]. Trading Information Summary - As of April 2, 2025, Prolo Pharmaceutical's stock closed at 15.29 RMB, down 0.91%, with a turnover rate of 0.75%, a trading volume of 88,000 shares, and a transaction amount of 135 million RMB [1]. - On the same day, the main funds experienced a net outflow of 18.1 million RMB, accounting for 13.4% of the total transaction amount [2][4]. - Retail investors saw a net inflow of 19.1 million RMB, representing 14.11% of the total transaction amount [2]. Company Announcement Summary - The company announced on February 19, 2025, that it would use its own funds to repurchase shares through centralized bidding, with the repurchase period set for 12 months from the board's approval date [2]. - As of March 31, 2025, Prolo Pharmaceutical had not yet executed any share repurchases through the designated securities account [2][4].